Fig. 1 (abstract O29).

Flow mediated dilatation in systemic autoimmune diseases (SAM): dermatomyositis (DM), antisynthetase syndrome (ASS), compared to health control (HC). *P<0.05
Flow mediated dilatation in systemic autoimmune diseases (SAM): dermatomyositis (DM), antisynthetase syndrome (ASS), compared to health control (HC). *P<0.05